| Patient | Ann Richards |
|---|---|
| Date of birth | 1933-09-01 |
| Identifiers | MRN HR-ML019-SYN-TD; SSN (made up) 000-19-3381 |
| Document date | 1997-02-10 |
| Author | Rosalind Teague, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for bone health after a fall with a hand fracture [S]
This fictional modern episode addresses the presenting concerns below. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
4 later historical claims are omitted because they describe events after the index age. See the teaching note.
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1980 | Heavy drinking, followed by treatment from which she emerged sober; no alcohol since | D (CLM-0003) |
| 1996 | Fall with a hand fracture (one account also describes a second fall with an ankle fracture); the year is 1996 in two sources and 1994 in one | D (CLM-0006) |
| 1996 | Bone density test after the fall, reported as osteopenia, an early stage of osteoporosis; no report or T-scores available | D (CLM-0005, CLM-0007) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Osteoporosis with fractures of the arm and hip and a curved upper back, by Richards's own public account; Richards said osteoporosis was not the cause of her mother's death but led to it | D (CLM-0004) |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cholecalciferol (vitamin D3) 50 mcg (1971 units) oral tablet, one tablet daily | One tablet by mouth daily | Oral route | 1997-02-10 | active | S |
Positive for the concerns in the history of present illness. Alert, quick-witted, and direct; asks pointed questions about her numbers. Mood good; PHQ-9 score 2 with item 9 scored 0; no thoughts of suicide or self-harm; no cravings. No other systems reported as affected in this synthetic episode. [S]
Alert and engaged. Independent in all activities of daily living and instrumental activities. Timed Up and Go 11 seconds; tandem stance held 8 seconds (below 10); 30-second chair stand 11; fall with fracture in the past year and fear of another fall when traveling. Standing height 164.0 cm by stadiometer, about 2 cm below her recalled tallest height of 166 cm; no kyphosis; occiput touches the wall. [S]
Vital signs recorded on 1997-02-10; see the Vital Signs section. Mental status: Alert, quick-witted, and direct; asks pointed questions about her numbers; Mood good; PHQ-9 score 2 with item 9 scored 0; no thoughts of suicide or self-harm; no cravings. The physical examination is limited to the findings relevant to this synthetic episode. [S]
Structured safety assessment: current ideation absent, intent absent, plan absent, access to means reviewed: yes. Routine outpatient care. Crisis resources, including the 988 Suicide & Crisis Lifeline, given in writing and saved in her phone; safety reviewed at each visit. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1997-02-10 | Body height | 164 | cm | S |
| 1997-02-10 | Body weight | 66 | kg | S |
| 1997-02-10 | Body mass index (BMI) [Ratio] | 24.5 | kg/m2 | S |
| 1997-02-10 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1997-02-10 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1997-02-10 | Heart rate | 72 | /min | S |
| 1997-02-10 | Respiratory rate | 14 | /min | S |
| 1997-02-10 | Body temperature | 36.6 | Cel | S |
| 1997-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1997-02-10 | DXA Lumbar spine [T-score] Bone density | -2.3 | {T-score} | -1.0 or higher is normal; between -1.0 and -2.5 is low bone mass (osteopenia); -2.5 or lower is osteoporosis | Low | S |
| 1997-02-10 | DXA Femur [T-score] Bone density | -2 | {T-score} | -1.0 or higher is normal; between -1.0 and -2.5 is low bone mass (osteopenia); -2.5 or lower is osteoporosis | Low | S |
| 1997-02-10 | DXA Hip [T-score] Bone density | -1.7 | {T-score} | -1.0 or higher is normal; between -1.0 and -2.5 is low bone mass (osteopenia); -2.5 or lower is osteoporosis | Low | S |
| 1997-02-10 | Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment | 22 | % | S | ||
| 1997-02-10 | Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment | 3.6 | % | S | ||
| 1997-02-10 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1997-02-10 | Albumin [Mass/volume] in Serum or Plasma | 4.2 | g/dL | 3.5-5 g/dL | Normal | S |
| 1997-02-10 | Creatinine [Mass/volume] in Serum or Plasma | 0.8 | mg/dL | 0.5-1 mg/dL | Normal | S |
| 1997-02-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1992)/1.73 sq M | 81 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1997-02-10 | Phosphate [Mass/volume] in Serum or Plasma | 3.5 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1997-02-10 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.4 mg/dL | Normal | S |
| 1997-02-10 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 84 | U/L | 40-120 U/L | Normal | S |
| 1997-02-10 | Parathyrin.intact [Mass/volume] in Serum or Plasma | 54 | pg/mL | 15-65 pg/mL | Normal | S |
| 1997-02-10 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 1997-02-10 | Hemoglobin [Mass/volume] in Blood | 13.3 | g/dL | 12-15.5 g/dL | Normal | S |
| 1997-02-10 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 21 | U/L | 7-35 U/L | Normal | S |
| 1997-02-10 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 24 | ng/mL | Target 30 ng/mL or higher before and during osteoporosis treatment | Low | S |
| 1997-02-10 | Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma | 560 | pg/mL | Postmenopausal reference interval 104 to 1008 pg/mL; a fall of more than about 30 percent on antiresorptive therapy indicates response | Normal | S |
| 1997-02-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 1997-02-10 | Total score [AUDIT-C] | 0 | {score} | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Low bone mass (osteopenia) of the lumbar spine and hip on DXA, lowest T-score -2.3 at the lumbar spine (femoral neck -2.0, total hip -1.7), with a 10-year FRAX risk above the treatment thresholds (major osteoporotic fracture 22 percent, hip 3.6 percent); not osteoporosis by T-score, but meets the AACE 1991 clinical criteria for osteoporosis (low bone mass with a FRAX risk above threshold) | active | confirmed | M85.89 | S — Synthetic modern DXA and FRAX classification linked to her publicly described osteopenia (early osteoporosis) after a fall with a hand fracture. |
| Alcohol use disorder in sustained remission for more than fifteen years, since treatment; no alcohol since | active | confirmed | F10.21 | S — Synthetic modern coding of her publicly described heavy drinking and long recovery; listed because remission protects bone and lowers fall risk, and it is reviewed at each visit. |
| History of falls: a fall from standing height with a hand fracture last year (and, in one account, a second fall with an ankle fracture); no falls since | active | confirmed | Z91.81 | S — Synthetic modern entry linked to her publicly described falls and fractures. |